EDGAR Filing Documents for 0001193125-04-141785

Form 10QSB - Optional form for quarterly and transition reports of small business issuers:

SEC Accession No. 0001193125-04-141785

Filing Date

2004-08-16

Accepted

2004-08-16 16:15:08

Documents

Period of Report

2004-06-30

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-QSB	d10qsb.htm	10QSB	312652
2	CONSULTING AGREEMENT BETWEEN INSERT THERAPEUTICS AND DR. MARK DAVIS	dex108.htm	EX-10.8	28828
3	CONSULTING AGREEMENT BETWEEN INSERT THERAPEUTICS AND NEOLOGIX, INC.	dex109.htm	EX-10.9	53713
4	AMENDMENT NO. 1 TO AGREEMENT TO PROVIDE ADDITIONAL CAPITAL	dex1010.htm	EX-10.10	9086
5	CONSULTING AGMT BETWEEN AONEX TECHNOLOGIES (FKA AONEX CORP.) & DR. HARRY ATWATER	dex1011.htm	EX-10.11	31613
6	AGREEMENT TO PROVIDE ADDITIONAL CAPITAL	dex1012.htm	EX-10.12	17398
7	RULE 13A-14(A)/15D-14(A) CERTIFICATION OF CHIEF EXECUTIVE OFFICER	dex311.htm	EX-31.1	6310
8	SECTION 1350 CERTIFICATION BY PRINCIPAL EXECUTIVE OFFICER	dex321.htm	EX-32.1	3201
	Complete submission text file	0001193125-04-141785.txt		465590

Mailing Address 1118 EAST GREEN STREET PASADENA CA 91106

Business Address 1118 EAST GREEN STREET PASADENA CA 91106 626-792-5549

ARROWHEAD RESEARCH CORP (Filer) CIK: 0000879407 (see all company filings)